Dongrui Wang Profile
Dongrui Wang

@dow072109

Followers
29
Following
5
Media
0
Statuses
49

Postdoctoral Fellow, MD Anderson Cancer Center PhD from City of Hope National Medical Center Cancer Immunotherapy; CAR T cells

Houston, TX
Joined December 2013
Don't wanna be here? Send us removal request.
@dow072109
Dongrui Wang
5 years
0
19
0
@dow072109
Dongrui Wang
6 years
A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity
0
0
1
@dow072109
Dongrui Wang
6 years
Re-defining GBM classification!.An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
0
0
2
@dow072109
Dongrui Wang
6 years
CSCs enrich for CD80 and inhibit T cell activity through CTLA-4 .Intrigued to see how much these cells alter in response to immunotherapy which is unfortunately not well elucidated here. Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells
0
0
1
@dow072109
Dongrui Wang
6 years
RT @biorxivpreprint: Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustio….
0
19
0
@dow072109
Dongrui Wang
6 years
RT @nickhaining: Some lovely work from @MartinLaFleur18 in a new paper from Arlene Sharpe's and my labs in @naturecomms. Ever wanted to CR….
0
50
0
@dow072109
Dongrui Wang
6 years
Engineering macrophages for tumor detection.
0
0
0
@dow072109
Dongrui Wang
6 years
Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells
0
0
1
@dow072109
Dongrui Wang
6 years
RT @SJMorrison_: We undermine the quality of our lives by torturing each other during peer review. Every #phd and #postdoc should be traine….
0
687
0
@dow072109
Dongrui Wang
7 years
NR4A depletion enhances CAR T cell function. Worth further investigation on how much of that effect comes from re-shaping endogenous immune response.
Tweet card summary image
nature.com
Nature - Transfer of NR4A-deficient T cells expressing chimeric antigen receptors is shown to reduce tumour burden and increase survival by shifting T cell transcriptional programs away from...
0
0
2
@dow072109
Dongrui Wang
7 years
combining MHC-I/II KO and CD47 overexpression to generate hypoimmunogeneic iPSCs for allogeneic transplantation.
nature.com
Nature Biotechnology - Genetic engineering prevents immune rejection of allogeneic cell transplants derived from iPSCs.
0
0
0
@dow072109
Dongrui Wang
7 years
Mass Cytometry Analysis Reveals that Specific Intratumoral CD4+ T Cell Subsets Correlate with Patient Survival in Follicular Lymphoma
0
0
1
@dow072109
Dongrui Wang
7 years
Proliferation tracing with single-cell mass cytometry optimizes generation of stem cell memory-like T cells.
0
0
1
@dow072109
Dongrui Wang
7 years
RT @parkerici: Giving checkpoint inhibitor before surgery nearly doubles survival of #glioblastoma patients–new PICI #cancer #immunotherapy….
0
17
0
@dow072109
Dongrui Wang
7 years
Back to back studies on neoadjuvant anti-PD1 therapy followed by post-surgery treatment cycles. Important insights for treating tumors with low immune infiltrates. Interesting that tumor cell cycle status was strongly affected.
0
1
0
@dow072109
Dongrui Wang
7 years
Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma
0
0
0
@dow072109
Dongrui Wang
7 years
Organoid Modeling of the Tumor Immune Microenvironment
0
1
3
@dow072109
Dongrui Wang
7 years
Noncoding regions are the main source of targetable tumor-specific antigens
0
0
0